In This Section      
 

PGY2 Thrombosis and Hemostasis Management Program

PGY2 Program Purpose

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Program Overview

The Johns Hopkins Hospital PGY-2 Thrombosis and Hemostasis Residency is twelve-month training and experience. The residency is currently in pre-candidate status with ASHP with plans to pursue accreditation after graduation of the first resident. The program provides flexibility to meet the interests and needs of the individual resident while at the same time ensuring the achievement of foundational skills for high quality thrombosis and hemostasis pharmacy practice. This residency provides experience to numerous patient populations within thrombosis and hemostasis and strives to produce experts in this area of practice. The residency will emphasize the resident’s interests while achieving the goals and objectives for PGY2 Thrombosis and Hemostasis Residencies set forth by ASHP. Additionally, The Johns Hopkins Hospital is one of four recipients of the Anticoagulation Forum TRAIN Grant for PGY2 Thrombosis and Hemostasis Residents in 2023-2024 and 2024-2025. As part of the TRAIN Grant, the resident and residency program director will participate in bimonthly topic discussions with the other TRAIN Grant sites.

Program Goals

Residents who complete this program will be prepared with the knowledge and clinical skills to become a clinical pharmacy specialist in thrombosis and hemostasis and serve as leaders in anticoagulation stewardship program development and implementation.

Orientation

The Pharmacy Residency Orientation experience provides a comprehensive and coordinated training program designed to provide incoming residents with an understanding of policies, procedures, and expectations for the pharmacy residency experience. During orientation, residents will participate in hospital, department, and division orientation, and will be exposed to department policies and resources.

Hospital and pharmacy department orientation is required for all new pharmacist hires at Johns Hopkins Hospital. The resident is expected to interact with members of the pharmacy department throughout orientation and to attend assigned orientation and training sessions.

Prior to the start of the residency program, residents will be given a full, detailed orientation itinerary.

Rotations

Required Rotations

  • Orientation (1 month)
  • Benign Hematology and Hematology Consults (2 months)
  • Hemostatic and Antithrombotic Stewardship (1 month)
  • Benign Hematology, Hematology Consults, and Antithrombotic Stewardship (2 months)
  • Cardiac Intensive Care Unit (CCU) (1 month)
  • General Cardiology (1 month)
  • Adult Medication Safety (1 month)
  • Ambulatory Anticoagulation Clinics (1 month)
  • Research (1 month)*
  • LVAD Anticoagulation Monitoring (Longitudinal 9-12 months)
  • Hemophilia Clinic (Longitudinal 9-12 months)

* will include 1-2 weeks of shadowing in special coagulation laboratory

Elective Rotations

  • May repeat any core rotation
  • Pediatric Cardiac Intensive Care Unit, Pediatric Benign Hematology, Cardiovascular Surgical Intensive Care Unit (Adults)

Education Components

  • Pharmacotherapy Rounds
    • All residents will provide a 30-minute presentation that is APCE accredited.
    • Please refer to the “Learning Opportunities” section of the Department of Pharmacy, Johns Hopkins Medicine website.
  • Journal Clubs and/or Topic Discussions
    • Biweekly topic discussions with four other Anticoagulation Forum TRAIN Grant sites
    • Participation in topic discussions for other programs as appropriate (e.g. cardiology, critical care)
  • Teaching Requirements
    • Each Hopkins resident is required to provide continuing education sessions.
    • The PGY2 Thrombosis and Hemostasis Resident will provide a 1-hour departmental continuing education presentation that is ACPE accredited (in addition to Pharmacotherapy Rounds)
    • A Teaching and Learning Certificate Program is available as an optional learning experience
    • Please refer to the “Learning Opportunities” section of the Department of Pharmacy, Johns Hopkins Medicine website.

Requirements for Acceptance to the Program

The qualified candidate will have a Doctor of Pharmacy degree from an ACPE accredited school of pharmacy. Prior to the beginning of a PGY2 residency, PGY2 residents must have successfully completed an ASHP-accredited PGY1 pharmacy residency program.

Licensure and Certification Requirements

All residents are required to obtain a Maryland State Pharmacy License by August 1st.

The resident will arrive at the program already ACLS certified, or will complete certification during the residency year.

Attendance at Professional Meetings

The department will support the resident (expense and leave time) to attend one professional conference. Any additional travel that is to be supported by the department is evaluated on a case-by-case basis.

Please refer to the “Meetings and Conferences” section of the Department of Pharmacy, Johns Hopkins Medicine website.

MUE Project

The resident must complete a research or quality improvement project. The scope, magnitude, and type of project will vary according to individual interests but must be completed in a manner suitable for presentation and publication.

Please refer to the “Projects” section of the Department of Pharmacy, Johns Hopkins Medicine website.

Drug Class Review (DCR) or Formulary Management Project

The resident will complete a drug class review as part of the formulary management process. This may be achieved through assisting in the determination of formulary additions/deletions by assessing therapeutic merits, safety, redundancies, and the estimated cost impact on the JHHS.

Committee Participation

The resident will be assigned to departmental, hospital, or health-system committee(s) over the course of the year. The resident will serve as the secretary of the Anticoagulation Steering Committee (multidisciplinary, multi-site committee) and Anticoagulation Steering Patient Safety Event Review Subcommittee. The PGY2 Thrombosis and Hemostasis resident will also serve as an active member of the Department of Pharmacy Anticoagulation Committee and Hemostatic and Antithrombotic Stewardship Committee.

Staffing Component

Each resident will practice as a pharmacist in a designated area throughout the residency year.

Please refer to the “Staffing Requirements” section of the Department of Pharmacy, Johns Hopkins Medicine

On-Call Coverage

The resident will participate in clinical on-call services. On-call duties include code response, drug information question responses, pharmacokinetic assessments, administrative assistance, and other duties. On-call hours are from 4 PM to 10 PM on weekdays and 8 AM to 8 PM on weekends and holidays. The frequency of on-call coverage depends upon the number of residents in the entire program and averages about 18 shifts per year.

Please refer to the “On Call Program” section of the Department of Pharmacy, Johns Hopkins Medicine website.

Paid Time Off (PTO)

Please refer to the “Benefits” section of the Department of Pharmacy, Johns Hopkins Medicine website.

Residency Program Director

Katie Dane, PharmD, BCPS
Clinical Pharmacy Specialist, Benign Hematology and Cardiology
Co-Director, Hemostatic and Antithrombotic Stewardship Program
The John Hopkins Hospital
Department of Pharmacy
600 North Wolfe Street, Carnegie 180
Baltimore, MD 21287-6180
Phone: 410-502-6769
Email: kdane2@jh.edu

Core Residency Preceptors

Jessica Chasler, PharmD, MPH, BCCP, BCPS
Clinical Pharmacy Specialist, General Cardiology

Katie Dane, PharmD, BCPS
Clinical Pharmacy Specialist, Benign Hematology/Antithrombotic Stewardship and Cardiac Care Unit

Stephanie Davis, PharmD, BCCCP, CNSC
Clinical Pharmacy Specialist, Cardiovascular Surgical Intensive Care and Clinical Nutrition Support

Rosemary Duncan, PharmD, BCPS
Adult Medication Safety Officer, Department of Pharmacy

John Lindsley, PharmD, BCCCP, BCCP, AACC
Clinical Pharmacy Specialist, Cardiac Care Unit and Benign Hematology/Antithrombotic Stewardship

Peggy Kraus, PharmD
Clinical Pharmacy Specialist, JHH Ambulatory Anticoagulation

David Procaccini, PharmD, MPH, BCPS, BCPPS, CACP, CPHQ
Clinical Pharmacy Specialist, Pediatric Cardiac Intensive Care, General Cardiology, and Heart Transplantation

Charlie Twilley, PharmD
Clinical Pharmacy Specialist, JHBMC Ambulatory Anticoagulation